HeartSciences

About HeartSciences

Incorporated in 2007, HeartSciences (formerly known as Heart Test Laboratories) is a privately held medical technology company located in the Dallas-Fort Worth metroplex, the largest economic area in the Southern United States. For a decade, HeartSciences has been dedicated to the development of accurate, affordable cardiac testing tools for the early detection of heart disease.

To date, HeartSciences has invested more than $30M in research and development in an effort to fundamentally improve the sensitivity of an electrocardiograph (ECG/EKG) for the early detection of heart disease. The ECG is a device that has not experienced significant clinical advancement in decades, until now.

MyoVista^® High Sensitivity ECG (hsECG™) Cardiac Testing Device, the industry’s first electrocardiographic device that applies proprietary use of Continuous Wavelet Transform (CWT) signal processing technology represents the first product from the years of research and development.

Mission

Enabling accurate, affordable screening for the early detection of heart disease.

The Problem

Heart Disease Is the Leading Cause of Death Worldwide

Advanced cardiac testing not often offered for asymptomatic patients

Traditional ECG Lack of sensitivity and are used for symptomatic patients to determine if a heart attack has taken place $50-$200

ECG based stress test – Improved sensitivity over standard ECG $250+

CT Scan – Used for obtaining a calcium score $200+

CT based Angiogram – An alternative to nuclear stress test $600+

Nuclear Stress Test – Test showing blood flow to the heart tissue $600+

Echocardiogram – Used for detecting structural abnormalities $500+

Invasive Angiogram – Gold standard for detecting CAD $5,000+

Lack of Innovation

MyoVista hsECG device provides low cost advanced testing to assist in the assessment of heart disease.
MyoVista hsECG device provides advanced testing to help detect cardiac disease, the leading cause of death and largest disease management spend in healthcare.
Effective testing can help shift focus to earlier lower cost treatments and better patient outcomes.
Targeting the Diagnostic gap – MyoVista hsECG device helps to address a lack of high quality tools for low cost heart testing.
MyoVista hsECG device is a simple, non-invasive, electrophysiology based medical device with innovative and intuitive user interface.

Our Solution: MyoVista^® High Sensitivity (hsECG™) Cardiac Testing Device

MyoVista hsECG device provides low cost, accurate testing to assist in the assessment of heart disease.
MyoVista hsECG device provides advanced testing to help detect cardiac disease, the leading cause of death and largest disease management spend in healthcare.
Effective testing can help shift focus to earlier lower cost treatments and better patient outcomes.
Targeting the Diagnostic gap – MyoVista hsECG device helps to address a lack of high quality tools for effective low cost heart testing.
MyoVista hsECG device is a simple, non-invasive, electrophysiology based medical device with innovative and intuitive user interface.

Incorporates Traditional ECG

Produces traditional ECG tracing with Glasgow Interpretive Analysis and proprietary MyoVista hsECG Informatics reporting
Familiar lead placement – no re-training
Ideal testing tool
Physician reimbursement
R&D completed
Targeting the “Diagnostic Gap”
Assists in reducing unnecessary expensive testing
Proper testing lowers overall healthcare costs
Beneficial for GP and Cardiologist

Leadership

News and Events

Investors Portal Login

HeartSciences enables accurate, affordable screening for the early detection of heart disease. MyoVista^® High-Sensitivity ECG (hsECG™) technology advances cardiac screening bridging the “diagnostic gap”, detecting cardiac dysfunction. MyoVista is a low cost, easy to adopt, highly sensitive test for asymptomatic and symptomatic patients. MyoVista- The Power of Wavelet Signal Processing.

Careers

To submit a resume and coverletter please send documents to careers@heartsciences.com

About HeartSciences

Mission

The Problem

Lack of Innovation

Our Solution: MyoVista^® High Sensitivity (hsECG™) Cardiac Testing Device

Incorporates Traditional ECG

Leadership

Chairman

CEO

Board Members

Management

Clinical Advisors

Advisors

News and Events

Investors Portal Login

Careers

About HeartSciences

Mission

The Problem

Lack of Innovation

Our Solution: MyoVista® High Sensitivity (hsECG™) Cardiac Testing Device

Incorporates Traditional ECG

Leadership

Chairman

CEO

Board Members

Management

Clinical Advisors

Advisors

News and Events

Investors Portal Login

Careers

HeartSciences

Our Solution: MyoVista^® High Sensitivity (hsECG™) Cardiac Testing Device